Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neuropsychopharmacology

• Publication date

  2000-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0893-133X(99)00148-7PMID 10731626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MDMA induced dopamine release in vivo: role of endogenous serotonin

  2005cited by this paper
• Is A Single Dose of MDMA Harmless

  1999cited by this paper
• 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

  1999cited by this paper
• Caveat Emptor: Researcher Beware

  1999cited by this paper
• Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study

  1999cited by this paper
• Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.

  1999cited by this paper
• Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

  1999cited by this paper
• An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

  1998cited by this paper
• Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

  1998cited by this paper
• The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans

  1998cited by this paper
• Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

  1998cited by this paper
• Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

  1998influential reference
• Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

  1996influential reference
• Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors

  1996cited by this paper
• Prolactin response to fenfluramine is independent of serotonin release.

  1996cited by this paper
• The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

  1996cited by this paper
• Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.

  1996influential reference
• Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)

  1995cited by this paper
• Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.

  1995cited by this paper
• Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.

  1994cited by this paper
• Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine

  1994cited by this paper
• The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

  1994cited by this paper
• Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.

  1993influential reference
• Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.

  1993cited by this paper
• Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.

  1993cited by this paper
• 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.

  1992cited by this paper
• The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

  1992influential reference
• The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

  1992cited by this paper
• Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

  1991influential reference
• Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.

  1991cited by this paper
• 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.

  1991cited by this paper
• 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.

  1990influential reference
• Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.

  1990cited by this paper
• Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices.

  1990cited by this paper
• 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.

  1989cited by this paper
• Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.

  1989cited by this paper
• 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.

  1988cited by this paper
• The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

  1988cited by this paper
• Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.

  1988cited by this paper
• Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

  1987influential reference
• In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.

  1987influential reference
• Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.

  1987cited by this paper
• Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.

  1986cited by this paper
• Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

  1982cited by this paper
• Das Freiburger Persönlichkeitsinventar (FPI) von J. Fahrenberg und H. Selg

  1971cited by this paper

• The effects of acute and repeated adolescent MDMA exposure on behavior, cognition, and the monoamine neurotransmitter systems: A review of human and pre-clinical research.

  2026cites this paper
• Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin.

  2026cites this paper
• History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA).

  2025cites this paper
• The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis.

  2025cites this paper
• MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study

  2025cites this paper
• MDMA in Psychiatry: From PTSD to emerging indications, safety, and future directions

  2025cites this paper
• Clinical pharmacology.

  2025cites this paper
• Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights

  2025cites this paper
• Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects

  2025cites this paper
• Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.

  2024cites this paper
• Aggressive Behaviours Associated with MDMA and Psychedelics: A narrative review.

  2024cites this paper
• Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats

  2024cites this paper
• The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?

  2024cites this paper
• Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”

  2024cites this paper
• Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine

  2024cites this paper
• Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles.

  2023cites this paper
• Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder

  2023cites this paper
• MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy.

  2023cites this paper
• Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex

  2023cites this paper
• Mephedrone induces partial release at human dopamine transporters but full release at human serotonin transporters.

  2023cites this paper
• Impact of fluoxetine preexposure on MDMA-induced taste avoidance in male and female rats.

  2022cites this paper
• White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels

  2022cites this paper
• A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders

  2022cites this paper
• Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice

  2022cites this paper
• Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

  2022cites this paper
• Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”

  2022cites this paper
• Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder

  2022cites this paper
• Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects

  2022cites this paper
• The Altered States Database: Psychometric data from a systematic literature review

  2022cites this paper
• Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review

  2022influential citation
• Serotonin-releasing agents with reduced off-target effects

  2022cites this paper
• MDMA for the Treatment of Negative Symptoms in Schizophrenia

  2022cites this paper
• MDMA related neuro-inflammation and adenosine receptors.

  2022cites this paper
• Ecstasy tablets: rapid identification and determination of enantiomeric excess of MDMA

  2021cites this paper
• Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse

  2021cites this paper
• Neurotoxicity of MDMA: Main effects and mechanisms.

  2021cites this paper
• Structural analysis of MDMA in solution by methods of chiroptical spectroscopy supported by DFT calculations

  2021cites this paper
• Dosing Psychedelics and MDMA.

  2021cites this paper
• Cognitive Empathy as Imagination: Evidence From Reading the Mind in the Eyes in Autism and Schizotypy

  2021cites this paper
• A Systematic Review of the MDMA Model to Address Social Impairment in Autism

  2021cites this paper
• Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

  2020cites this paper
• Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo

  2020cites this paper
• Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?

  2020influential citation
• Novel Phenethylamines and their Potential Interactions with Prescription Drugs: A Systematic Critical Review.

  2020cites this paper
• Acute subjective effects in LSD- and MDMA-assisted psychotherapy

  2020cites this paper
• RETRACTED ARTICLE: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy

  2020cites this paper
• Serotonin and serotonin receptors in hallucinogen action

  2020cites this paper
• Cognitive consequences of 3,4-methylenedioxymethamphetamine use

  2020cites this paper
• Stereochemistry of phase‐1 metabolites of mephedrone determines their effectiveness as releasers at the serotonin transporter

  2019cites this paper
• No Influence of Dopamine System Gene Variations on Acute Effects of MDMA

  2019cites this paper
• A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

  2019cites this paper
• "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.

  2019cites this paper
• Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

  2019cites this paper
• Effects of MDMA on attention to positive social cues and pleasantness of affective touch

  2019cites this paper
• 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors

  2019cites this paper
• NOVE SINTETIČKE (DIZAJNIRANE) DROGE

  2018cites this paper
• Monoamine Transporter and Receptor Interaction Profiles of Synthetic Cathinones

  2018cites this paper
• Separating the agony from ecstasy: R(–)‐3,4‐methylenedioxymethamphetamine has prosocial and therapeutic‐like effects without signs of neurotoxicity in mice

  2018cites this paper
• Global Health Impact of Major Classes of “Designer Drugs”: Structural, Pharmacological and Toxicological Overview

  2018cites this paper
• Hallucinogen persisting perception disorder: A literature review and three case reports

  2018cites this paper
• Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter

  2018cites this paper
• (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA

  2018cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• Key interindividual determinants in MDMA pharmacodynamics

  2018cites this paper
• Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects.

  2018cites this paper
• Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens

  2018cites this paper
• Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects

  2017cites this paper
• The Mediating Role of A2A Adenosine Receptors in the Mitochondrial Pathway of Apoptotic Hippocampal Cell Death, Following the Administration of MDMA in Rat

  2017cites this paper
• Effects of MDMA on the pupillary light reflex on its own and after pretreatment with reboxetine , duloxetine , clonidine , carvedilol , and doxazosin

  2017cites this paper
• 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner

  2017cites this paper
• État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21e siècle

  2017cites this paper
• Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.

  2016cites this paper
• Race-Based Trauma : The Challenge and Promise of MDMA-Assisted Psychotherapy

  2016cites this paper
• Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)

  2016cites this paper
• Neurochemical substrates of the rewarding effects of MDMA: implications for the development of pharmacotherapies to MDMA dependence

  2016cites this paper
• The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

  2016cites this paper
• Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.

  2016cites this paper
• Enhancing exposure therapy efficacy for posttraumatic stress disorder

  2016cites this paper
• Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method.

  2016cites this paper
• The effect of MDMA self-administration on MDMA-produced hyperactivity and c-fos expression

  2016cites this paper
• Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

  2015cites this paper
• Influence of Bupropion on the Effects of MDMA

  2015cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6o ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO INTEGRADO EM MEDICINA

  2015cites this paper
• The role of serotonin in drug use and addiction.

  2015cites this paper
• The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder

  2015cites this paper
• The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

  2015influential citation
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cites this paper
• Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects

  2015cites this paper
• The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine

  2015cites this paper
• The Role Of Sertonin And Vesicular Monoamine Transporters In The Adverse Responses To Methylenedioxymethamphetamine

  2014cites this paper
• Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.

  2014influential citation
• Strategic control, consolidation and poly-drug use; the relative contributions to verbal memory impairment in recreational ecstasy users

  2014cites this paper
• Is ecstasy-induced protracted symptom of motion perception associated with altered regional homogeneity of brain?

  2014cites this paper
• Maternal MDMA administration in mice leads to neonatal growth delay.

  2014cites this paper
• Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

  2014cites this paper
• The highs and lows of drugs use: acute effects of cannabis, cocaine and MDMA on impulsivity, cognition and subjective experience

  2014cites this paper
• Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.

  2014influential citation
• Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake

  2014cites this paper
• Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

  2014cites this paper
• MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro

  2014cites this paper